172 related articles for article (PubMed ID: 30305606)
101. Targeted Epigenetic Interventions in Cancer with an Emphasis on Pediatric Malignancies.
Gaál Z
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671446
[TBL] [Abstract][Full Text] [Related]
102. Targets of histone H3 lysine 9 methyltransferases.
Levinsky AJ; McEdwards G; Sethna N; Currie MA
Front Cell Dev Biol; 2022; 10():1026406. PubMed ID: 36568972
[TBL] [Abstract][Full Text] [Related]
103. Mechanisms behind context-dependent role of glucocorticoids in breast cancer progression.
Butz H; Patócs A
Cancer Metastasis Rev; 2022 Dec; 41(4):803-832. PubMed ID: 35761157
[TBL] [Abstract][Full Text] [Related]
104. Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2.
Ang GCK; Gupta A; Surana U; Yap SXL; Taneja R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740522
[TBL] [Abstract][Full Text] [Related]
105. Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor.
Singh B; Sarli VN; Lucci A
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681611
[TBL] [Abstract][Full Text] [Related]
106. Structure, Activity, and Function of the Protein Lysine Methyltransferase G9a.
Poulard C; Noureddine LM; Pruvost L; Le Romancer M
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685453
[TBL] [Abstract][Full Text] [Related]
107. How Protein Methylation Regulates Steroid Receptor Function.
Malbeteau L; Pham HT; Eve L; Stallcup MR; Poulard C; Le Romancer M
Endocr Rev; 2022 Jan; 43(1):160-197. PubMed ID: 33955470
[TBL] [Abstract][Full Text] [Related]
108. Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.
Noureddine LM; Trédan O; Hussein N; Badran B; Le Romancer M; Poulard C
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923160
[TBL] [Abstract][Full Text] [Related]
109. Sensitizing multidrug-resistant leukemia cells to common cytostatics by an aluminium-salen complex that has high-apoptotic effects in leukemia, lymphoma and mamma carcinoma cells.
Hopff SM; Onambele LA; Brandenburg M; Berkessel A; Prokop A
Biometals; 2021 Apr; 34(2):211-220. PubMed ID: 33560473
[TBL] [Abstract][Full Text] [Related]
110. Gene-Specific Actions of Transcriptional Coregulators Facilitate Physiological Plasticity: Evidence for a Physiological Coregulator Code.
Stallcup MR; Poulard C
Trends Biochem Sci; 2020 Jun; 45(6):497-510. PubMed ID: 32413325
[TBL] [Abstract][Full Text] [Related]
111. Huai Qi Huang Potentiates Dexamethasone-Mediated Lethality in Acute Lymphoblastic Leukemia Cells by Upregulating Glucocorticoid Receptor α.
Xu W; Wang Z; Li K; Jin R
Med Sci Monit; 2020 Feb; 26():e921649. PubMed ID: 32065117
[TBL] [Abstract][Full Text] [Related]
112. Effects of rhubarb on the expression of glucocorticoids receptor and regulation of cellular immunity in burn-induced septic rats.
Liu J; Li G; Chen YZ; Zhang LD; Wang T; Wen ZL; Wang L; Chen DC
Chin Med J (Engl); 2019 May; 132(10):1188-1193. PubMed ID: 31140990
[TBL] [Abstract][Full Text] [Related]
113. Increasing G9a automethylation sensitizes B acute lymphoblastic leukemia cells to glucocorticoid-induced death.
Poulard C; Baulu E; Lee BH; Pufall MA; Stallcup MR
Cell Death Dis; 2018 Oct; 9(10):1038. PubMed ID: 30305606
[TBL] [Abstract][Full Text] [Related]
114. A post-translational modification switch controls coactivator function of histone methyltransferases G9a and GLP.
Poulard C; Bittencourt D; Wu DY; Hu Y; Gerke DS; Stallcup MR
EMBO Rep; 2017 Aug; 18(8):1442-1459. PubMed ID: 28615290
[TBL] [Abstract][Full Text] [Related]
115. Relapse-associated AURKB blunts the glucocorticoid sensitivity of B cell acute lymphoblastic leukemia.
Poulard C; Kim HN; Fang M; Kruth K; Gagnieux C; Gerke DS; Bhojwani D; Kim YM; Kampmann M; Stallcup MR; Pufall MA
Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3052-3061. PubMed ID: 30733284
[TBL] [Abstract][Full Text] [Related]
116. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
[TBL] [Abstract][Full Text] [Related]
117. Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression.
Saha N; Muntean AG
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188498. PubMed ID: 33373647
[TBL] [Abstract][Full Text] [Related]
118. Hypoxia-Inducible Lysine Methyltransferases: G9a and GLP Hypoxic Regulation, Non-histone Substrate Modification, and Pathological Relevance.
Chopra A; Cho WC; Willmore WG; Biggar KK
Front Genet; 2020; 11():579636. PubMed ID: 33088284
[TBL] [Abstract][Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
